Table 3.
Screened respiratory articles included and deleted
|
|
Author & Year |
Included |
Deleted |
Reason for deletion/Notes |
|
1. |
Agado & Bowen 201233 SR pneumonia or COPD |
|
XX |
RCTs included along with other studies; outcome association vs. causal |
|
2. |
Astvaldsdóttir et al. 201834 Knowledge |
|
XX |
Focus on knowledge vs. causal |
|
3. |
Azarpazhooh & Leake 200635 SR of association between respiratory diseases and oral health |
|
XX |
Association investigated vs. not a causal relationship; too old |
|
4. |
Cagnani et al. 201636 SR aspiration pneumonia |
|
XX |
No RCTs included in SR (case studies, cohort; lots of weaknesses) |
|
5. |
Gomes-Filho et al. 202037 SR/MA |
|
XX |
No RCTs included in SR |
|
6. |
Gu et al. 201216 SR/MA toothbrushing |
XX |
|
|
|
7. |
Hua et al. 201617 Cochrane, SR/MA VAP; OH care |
XX
|
|
|
|
8. |
Veitz-Keenan & Ferraiolo 201738 Summary review of Hua |
|
XX |
Summary review of Hua (which is included) |
|
9. |
Kaneoka et al. 201518 SR/MA NV-HAP w/o mechanical ventilation |
XX |
|
|
|
10.
|
Klompas et al. 201419 SR/MA VAP Reappraisal of routine use of CHX |
XX |
|
|
|
11. |
Labeau et al. 201120 SR/MA VAP-CHX, P-Iodine |
XX
|
|
|
|
12. |
Li et al. 201521 SR/MA Antiseptics prevention of VAP |
XX |
|
|
|
13. |
Liu et al. 201822 Cochrane, SR/MA Prevention nursing home-acquired pneumonia |
XX
|
|
|
|
14. |
Mitchell et al. 201939 SR NV-HAP |
|
XX |
Only 6 of 15 included studies are RCTs; no separate analysis of the 6 |
|
15. |
Scannapieco 201440 COPD summary review of Peter |
|
XX |
Summary review and no RCTs in the Peter study (case-control study) |
|
16. |
Sjögren et al. 200823 SR/MA OH effect pneumonia & respiratory diseases |
XX
|
|
|
|
17. |
Sjögren et al. 201641 SR/MA Older with pneumonia in hospitals or nursing homes |
|
XX |
Poorly reported; poor definition of groups and terms |
|
18. |
Shi et al. 201324 SR/MA, VAP, CHX |
XX
|
|
|
|
19. |
Richards 201342 EBD review of Shi |
|
XX |
Summary review of Shi (which is included)
|
|
20. |
Spreadborough et al. 201643 VAP
|
|
XX |
No RCTs included in SR |
|
21. |
van der Maarel-Wierink et al. 201144
|
|
XX |
No RCTs included in SR |
|
22. |
Villar et al. 201625 SR/MA, VAP (CHX)
|
XX |
|
|
|
23. |
Zeng et al. 201245 MA, COPD |
|
XX |
No RCTs included in SR
|
|
24. |
Zeng et al. 201646 Lung CA risk |
|
XX |
No RCTs included in SR Risk of lung CA association |
|
25. |
Zhou et al. 201147 COPD, quality of life |
|
XX |
N/A to PICO and no RCTs in SR |